Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill (2016 - 2026)

Myriad Genetics has reported Goodwill over the past 15 years, most recently at $51.6 million for Q4 2025.

  • Quarterly Goodwill fell 81.98% to $51.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.6 million through Dec 2025, down 81.98% year-over-year, with the annual reading at $51.6 million for FY2025, 81.98% down from the prior year.
  • Goodwill was $51.6 million for Q4 2025 at Myriad Genetics, roughly flat from $51.6 million in the prior quarter.
  • Over five years, Goodwill peaked at $328.3 million in Q1 2021 and troughed at $51.6 million in Q2 2025.
  • The 5-year median for Goodwill is $286.3 million (2024), against an average of $239.1 million.
  • Year-over-year, Goodwill rose 21.18% in 2023 and then plummeted 81.98% in 2025.
  • A 5-year view of Goodwill shows it stood at $239.2 million in 2021, then increased by 19.9% to $286.8 million in 2022, then grew by 0.21% to $287.4 million in 2023, then dropped by 0.38% to $286.3 million in 2024, then crashed by 81.98% to $51.6 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Goodwill are $51.6 million (Q4 2025), $51.6 million (Q3 2025), and $51.6 million (Q2 2025).